These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 33865513)

  • 1. Out-of-pocket expenditure for administration of benzathine penicillin G injections for secondary prophylaxis in patients with rheumatic heart disease: A registry-based data from a tertiary care center in Northern India.
    Arvind B; Saxena A; Kazi DS; Bolger AF
    Indian Heart J; 2021; 73(2):169-173. PubMed ID: 33865513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intramuscular versus enteral penicillin prophylaxis to prevent progression of rheumatic heart disease: Study protocol for a noninferiority randomized trial (the GOALIE trial).
    Rwebembera J; Ndagire E; Carvalho N; Webel AR; Sable C; Okello E; Sarnacki R; Spaziani AM; Mucunguzi A; Engelman D; Grobler A; Steer A; Beaton A
    Am Heart J; 2024 Sep; 275():74-85. PubMed ID: 38797460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determining the impact of Benzathine penicillin G prophylaxis in children with latent rheumatic heart disease (GOAL trial): Study protocol for a randomized controlled trial.
    Beaton A; Okello E; Engelman D; Grobler A; Scheel A; DeWyer A; Sarnacki R; Omara IO; Rwebembera J; Sable C; Steer A
    Am Heart J; 2019 Sep; 215():95-105. PubMed ID: 31301533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary prevention of rheumatic heart disease in Ethiopia: a multicenter study.
    Belay W; Dessie A; Ahmed H; Gedlu E; Mariyo A; Shehibo A; Tigabu Z; Aliyu MH; Soslow J
    BMC Cardiovasc Disord; 2022 Feb; 22(1):26. PubMed ID: 35109807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement in rheumatic fever and rheumatic heart disease management and prevention using a health centre-based continuous quality improvement approach.
    Ralph AP; Fittock M; Schultz R; Thompson D; Dowden M; Clemens T; Parnaby MG; Clark M; McDonald MI; Edwards KN; Carapetis JR; Bailie RS
    BMC Health Serv Res; 2013 Dec; 13():525. PubMed ID: 24350582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High risk of early sub-therapeutic penicillin concentrations after intramuscular benzathine penicillin G injections in Ethiopian children and adults with rheumatic heart disease.
    Ketema EB; Gishen NZ; Hailu A; Leul A; Hadgu A; Hagos K; Berhane S; Tsega T; Page-Sharp M; Davis TM; Moore B; Batty KT; Carapetis J; Salman S; Manning L
    PLoS Negl Trop Dis; 2021 Jun; 15(6):e0009399. PubMed ID: 34115748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benzathine penicillin adherence for secondary prophylaxis among patients affected with rheumatic heart disease attending Mulago Hospital.
    Musoke C; Mondo CK; Okello E; Zhang W; Kakande B; Nyakoojo W; Freers J
    Cardiovasc J Afr; 2013 May; 24(4):124-9. PubMed ID: 24217043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to secondary prevention of rheumatic fever and rheumatic heart disease in young people: an 11-year retrospective study.
    Liaw J; Gorton S; Heal C; White A
    Aust N Z J Public Health; 2022 Dec; 46(6):758-763. PubMed ID: 35616403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative examination of secondary prophylaxis in rheumatic heart disease: factors influencing adherence to secondary prophylaxis in Uganda.
    Huck DM; Nalubwama H; Longenecker CT; Frank SH; Okello E; Webel AR
    Glob Heart; 2015 Mar; 10(1):63-69.e1. PubMed ID: 25754568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population pharmacokinetic study of benzathine benzylpenicillin G administration in children and adolescents with rheumatic heart disease: new insights for improved secondary prophylaxis strategies.
    Hand RM; Salman S; Newall N; Vine J; Page-Sharp M; Bowen AC; Gray K; Baker A; Kado J; Joseph J; Marsh J; Ramsay J; Sika-Paotonu D; Batty KT; Manning L; Carapetis J
    J Antimicrob Chemother; 2019 Jul; 74(7):1984-1991. PubMed ID: 30989171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adequate adherence to benzathine penicillin secondary prophylaxis following the diagnosis of rheumatic heart disease by echocardiographic screening.
    Culliford-Semmens N; Tilton E; Webb R; Lennon D; Paku B; Malcolm J; French S; Blair N; Wilson N
    N Z Med J; 2017 Jun; 130(1457):50-57. PubMed ID: 28617789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adherence to Benzathine Penicillin G Secondary Prophylaxis and Its Determinants in Patients with Rheumatic Heart Disease at a Cardiac Center of an Ethiopian Tertiary Care Teaching Hospital.
    Mekonen KK; Yismaw MB; Abiye AA; Tadesse TA
    Patient Prefer Adherence; 2020; 14():343-352. PubMed ID: 32110000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compliance of secondary prophylaxis for controlling rheumatic fever and rheumatic heart disease in a rural area of northern India.
    Kumar R; Thakur JS; Aggarwal A; Ganguly NK
    Indian Heart J; 1997; 49(3):282-8. PubMed ID: 9291651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous infusion of high-dose benzathine penicillin G is safe, tolerable, and suitable for less-frequent dosing for rheumatic heart disease secondary prophylaxis: a phase 1 open-label population pharmacokinetic study.
    Kado J; Salman S; Hla TK; Enkel S; Henderson R; Hand RM; Hort A; Page-Sharp M; Batty K; Moore BR; Bennett J; Anderson A; Carapetis J; Manning L
    Antimicrob Agents Chemother; 2023 Dec; 67(12):e0096223. PubMed ID: 37971244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic study of benzathine penicillin G administration in Indigenous children and young adults with rheumatic heart disease in the Northern Territory, Australia.
    Kado J; Salman S; Hand R; O'Brien M; Ralph A; Bowen AC; Page-Sharp M; Batty KT; Dolman V; Francis JR; Carapetis J; Manning L
    J Antimicrob Chemother; 2022 Sep; 77(10):2679-2682. PubMed ID: 35822635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a sustained release implant of benzathine penicillin G for secondary prophylaxis of rheumatic heart disease.
    Barr RK; Barber BW; Tait JR; Landersdorfer CB; Salman S; Musk GC; Page-Sharp M; Batty KT; Kado J; Manning L; Carapetis JR; Boyd BJ
    Eur J Pharm Biopharm; 2023 Aug; 189():240-250. PubMed ID: 37354997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillin Dried Blood Spot Assay for Use in Patients Receiving Intramuscular Benzathine Penicillin G and Other Penicillin Preparations To Prevent Rheumatic Fever.
    Page-Sharp M; Coward J; Moore BR; Salman S; Marshall L; Davis TME; Batty KT; Manning L
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sharing success - understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease.
    Chamberlain-Salaun J; Mills J; Kevat PM; Rémond MG; Maguire GP
    BMC Cardiovasc Disord; 2016 Aug; 16(1):166. PubMed ID: 27581750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence rates and risk factors for suboptimal adherence to secondary prophylaxis for rheumatic fever.
    Kevat PM; Gunnarsson R; Reeves BM; Ruben AR
    J Paediatr Child Health; 2021 Mar; 57(3):419-424. PubMed ID: 33340191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rheumatic Heart Disease Treatment Cascade in Uganda.
    Longenecker CT; Morris SR; Aliku TO; Beaton A; Costa MA; Kamya MR; Kityo C; Lwabi P; Mirembe G; Nampijja D; Rwebembera J; Sable C; Salata RA; Scheel A; Simon DI; Ssinabulya I; Okello E
    Circ Cardiovasc Qual Outcomes; 2017 Nov; 10(11):. PubMed ID: 29133472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.